Research ArticleCancer

Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia

See allHide authors and affiliations

Science Translational Medicine  11 Apr 2018:
Vol. 10, Issue 436, eaao3003
DOI: 10.1126/scitranslmed.aao3003

Article Information

vol. 10 no. 436

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 5, 2017
  • Resubmitted February 12, 2018
  • Accepted for publication March 23, 2018

Author Information

  1. Luis A. Carvajal1,
  2. Daniela Ben Neriah1,
  3. Adrien Senecal2,
  4. Lumie Benard1,
  5. Victor Thiruthuvanathan1,
  6. Tatyana Yatsenko1,
  7. Swathi-Rao Narayanagari1,3,
  8. Justin C. Wheat1,
  9. Tihomira I. Todorova1,
  10. Kelly Mitchell1,
  11. Charles Kenworthy2,
  12. Vincent Guerlavais4,
  13. D. Allen Annis4,
  14. Boris Bartholdy1,
  15. Britta Will1,3,5,6,
  16. Jesus D. Anampa5,
  17. Ioannis Mantzaris5,
  18. Manuel Aivado4,
  19. Robert H. Singer2,
  20. Robert A. Coleman2,
  21. Amit Verma3,5,6 and
  22. Ulrich Steidl1,3,5,6,*
  1. 1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  2. 2Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  3. 3Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  4. 4Aileron Therapeutics, Cambridge, MA 02139, USA.
  5. 5Division of Hemato-Oncology, Department of Medicine (Oncology), Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  6. 6Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  1. *Corresponding author. Email: ulrich.steidl{at}einstein.yu.edu

Altmetric

Article usage

Article usage: April 2018 to October 2018

AbstractFullPdf
Apr 20187979357765
May 201885184248
Jun 201863055164
Jul 201847174138
Aug 201819410384
Sep 20182709071
Oct 20186433121